Furie M B, McHugh D D
Department of Pathology, School of Medicine, State University of New York, Stony Brook 11794-8691.
J Immunol. 1989 Nov 15;143(10):3309-17.
To study the effects of the cytokines IL-1 and TNF-alpha on the transendothelial migration of neutrophils, human umbilical vein endothelial cells (HUVEC) were grown to confluence on connective tissue prepared from human amniotic membrane. Pretreatment of HUVEC-amnion cultures with rIL-1 beta (7.5 ng/ml) or rTNF-alpha (5 ng/ml) for 4 h resulted in rapid migration of from 20 to 50% of subsequently added neutrophils across the endothelial monolayer. In contrast, only 3 +/- 3% of added neutrophils penetrated the HUVEC monolayer in the absence of any stimulus. The number of neutrophils that migrated across cytokine-treated HUVEC was similar to the number that traversed untreated monolayers in response to gradients of FMLP; in addition, it was only 35% less than the number of neutrophils that migrated in response to leukotriene B4. No consistent additive effect was seen when migration was induced by both cytokine pretreatment of the HUVEC and a chemotactic gradient. The number of neutrophils that migrated across IL-1-treated cultures was proportional to the number added over the range of 2.5 x 10(5) to 4 x 10(6) neutrophils. When used at optimal concentrations, IL-1 and TNF-alpha were equally effective in stimulating neutrophil migration; no additive effect was seen when HUVEC were pretreated with optimal doses of both cytokines together. Direct addition of IL-1 or TNF-alpha to a 1-h migration assay had no effect on neutrophil adhesion to or migration across HUVEC, either in the presence or absence of a chemotactic gradient. Stimulation of neutrophil transendothelial migration in this system did not appear to be caused by adsorption of cytokine by the amniotic tissue, nor was it due to contamination of the cytokine preparations by LPS. These results suggest that IL-1 and TNF-alpha, generated at sites of inflammation, may act upon the endothelium to promote emigration of neutrophils from the vasculature.
为研究细胞因子白细胞介素 -1(IL -1)和肿瘤坏死因子 -α(TNF -α)对中性粒细胞跨内皮迁移的影响,将人脐静脉内皮细胞(HUVEC)接种于用人羊膜制备的结缔组织上,使其生长至汇合。用重组人白细胞介素 -1β(rIL -1β,7.5 ng/ml)或重组人肿瘤坏死因子 -α(rTNF -α,5 ng/ml)对HUVEC -羊膜培养物预处理4小时,导致随后添加的中性粒细胞中有20%至50%迅速穿过内皮单层迁移。相比之下,在没有任何刺激的情况下,只有3±3%的添加中性粒细胞穿透HUVEC单层。穿过细胞因子处理的HUVEC迁移的中性粒细胞数量与响应FMLP梯度穿过未处理单层的中性粒细胞数量相似;此外,它仅比响应白三烯B4迁移的中性粒细胞数量少35%。当通过HUVEC的细胞因子预处理和趋化梯度诱导迁移时,未观察到一致的累加效应。穿过IL -1处理培养物迁移的中性粒细胞数量与在2.5×10⁵至4×10⁶个中性粒细胞范围内添加的数量成正比。当以最佳浓度使用时,IL -1和TNF -α在刺激中性粒细胞迁移方面同样有效;当用两种细胞因子的最佳剂量一起预处理HUVEC时,未观察到累加效应。在1小时迁移试验中直接添加IL -1或TNF -α,无论是否存在趋化梯度,对中性粒细胞与HUVEC的黏附或跨HUVEC的迁移均无影响。在该系统中刺激中性粒细胞跨内皮迁移似乎不是由羊膜组织吸附细胞因子引起的,也不是由于细胞因子制剂被LPS污染所致。这些结果表明,在炎症部位产生的IL -1和TNF -α可能作用于内皮,以促进中性粒细胞从脉管系统中移出。